Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9879024
SERIAL NO

14820916

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a new forms of (R)-N-methylnaltrexone, and compositions thereof, useful as a peripheral mu opioid receptor antagonist.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROGENICS PHARMACEUTICALS INC331 TREBLE COVE RD N BILLERICA MA 01862

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Al, Shareffi Kadum A Greensboro, US 11 58
Boyd, Thomas A Encinitas, US 36 672
Perez, Julio Tarrytown, US 20 288
Shah, Syed M Delray Beach, US 119 920
Smolenskaya, Valeriya N West Lafayette, US 9 38

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 30, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 30, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00